Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and
Use of Proceeds
On
February
5,
2020,
our
board
of
directors
approved
the
replenishment
of
our
existing
share
repurchase
authorization
to
repurchase up to an aggregate of $100 million of common stock. The authorization
has no expiration date.
The table
below presents
information relating
to purchases
of shares
of our
common stock
during the
second quarter
of fiscal
2025:
Table 22
(a)
(b)
(c)
(d)
Period
Total
number
of shares
purchased
Average price
paid per share
(US dollars)
Total
number of shares
purchased as part of publicly
announced plans or
programs
Maximum dollar value of
shares that may yet be
purchased under the plans
or programs
Oct 1, 2024 - Oct 31, 2024
(1)
2,601,410
4.59
-
100,000,000
Nov 1, 2024 - Nov 30, 2024
(2)
61,821
4.96
-
100,000,000
Dec 1, 2024 - Dec 31, 2024
(2)
70,326
4.99
-
100,000,000
Total
2,733,557
-
(1)
Relates to
the repurchase
of
2,601,410
shares of
our
common
stock from
Crossfin
Holdings
(RF)
Proprietary
Limited
in
connection with our acquisition of Adumo. These shares do not reduce
the repurchase authority under the share repurchase program.
(2) Relates to the delivery of 61,821 and 70,326 shares of our common stock in November and December, respectively,
to us by
certain
of our
employees to
settle their
income
tax liabilities.
These shares
do not
reduce the
repurchase
authority under
the
share
repurchase program.
Other than as
reported in a
Current Report on
Form 8-K, we
did not
sell any
securities that
were not registered
under the Securities
Act during the second quarter of fiscal 2025.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.